FDA clears Park’s MCAT system
Park Medical Systems of Lachine, Quebec, has received the Foodand Drug Administration's go-ahead to market its Molecular CodedAperture Technology (MCAT), a collimator-based method for improvinggamma camera imaging at all energy levels.MCAT consists of
Park Medical Systems of Lachine, Quebec, has received the Foodand Drug Administration's go-ahead to market its Molecular CodedAperture Technology (MCAT), a collimator-based method for improvinggamma camera imaging at all energy levels.
MCAT consists of macro-collimators that attach to standard detectors,creating a coded pattern that is detected by the camera's photomultipliertube array. Software decodes the pattern into a high-resolutionimage covering a wide range of energies. Park believes the techniqueis more versatile than coincidence-detection methods for oncologyimaging.
Park will show the MCAT module, as well as clinical images, atthe Society of Nuclear Medicine meeting in San Antonio, TX, inJune.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
